Endpoints News
Buffett bets big on UnitedHealth Read in browser
Endpoints News
Tuesday, 19 August 2025
Thank you for reading, dupa dupackia!
basic
UPGRADE
2025'S BREAKOUT STARTUPS. WHO'S ON THE LIST? - Endpoints 11
Endpoints News returns to Boston’s State Room to announce the 2025 class of biotechs worth watching. Join the live unveiling and see the industry’s next chapter come into focus. Which biotechs will make the leap? Join us.
More than cycle tracking
Last week, women’s health unicorn Maven Clinic announced a new cycle tracking tool and male fertility testing as part of its women and family health virtual clinic. 
Of course, Maven, the $1.7 billion startup that works with employers to offer fertility and family benefits, is not the first to launch a cycle tracking tool — there are plenty of consumer apps out there that do the same thing.
But this summer, there's been a noticeable number of reproductive and women's health companies that are expanding the services they offer: Tia Health, for instance, partnered with Talkspace for mental health services, while TwentyEight Health and Carrot added weight care services. 
Maven CEO Kate Ryder said adding the cycle tracker and male fertility testing has to do with needing more data. She said she’s focused on looking at what will change in the next three years, and the role AI will play in sifting through information.
“If you think about where the market's going to be in three years from now, it's going to look completely different,” Ryder told me. For Maven, that means building for a future in which AI is involved in reading diagnostics and imaging, as well as replacing a lot of the administrative tasks in healthcare.
To confront that AI-embedded future, datapoints like ones you might get from a cycle-tracker are key. 
“An ovulation tracker, in the context of a larger platform, is just another input that becomes important to give a full view on someone's health, and then help them action on it,” Ryder said. Ideally with more data, people looking to have a baby will be able to do it without using interventions like IVF — or if they do need fertility care, they come armed with more data. 
Because it’s faster now to build features like a cycle tracker than it used to be — and it can be done in-house, rather than via acquisition — the goal for Maven is to be “complete specialty for women’s and family health and that front virtual door,” she said.
In this age of AI, I expect we’ll see more moves to be comprehensive like this from health tech companies. 
- Lydia
Here’s what’s new
Exclusive: Longevity startup Superpower is cutting its price by 60%
Su­per­pow­er, a start­up that tells peo­ple about their health based on blood test re­sults, is cut­ting its price down to $199 a year, End­points News learned.
GoodRx, Novo Nordisk partner to offer discounted GLP-1s at the pharmacy counter
GoodRx users will now be able to get all strengths of Ozem­pic and We­govy in­jec­tions at a cash price of $499 per month, thanks to a new col­lab­o­ra­tion be­tween the pre­scrip­tion drug dis­count com­pa­ny and phar­ma gi­ant No­vo Nordisk.
Cash price at the pharmacy
A stock chart shows GoodRx's stock climbing 37% on Monday.

GoodRx’s stock surged 37% on Monday after sharing that it is working with Novo on discounts to GLP-1s at pharmacies. “GoodRx's new management team has been working hard to leverage its marketplace DNA to drive incremental value through additional services,” Leerink’s Michael Cherney wrote in a note Monday, adding that the company showed progress in the second quarter. “This represents another important opportunity.”

This week in health Тech
Warren Buffett’s Berkshire Hathaway took a $1.6 billion stake in UnitedHealth Group. The move came as a surprise, given some of Buffett’s past comments on healthcare. With the launch of a joint venture with JP Morgan and Amazon, Buffett had called healthcare costs a “hungry tapeworm” on the economy. 

“While UNH shares are optically inexpensive – which we know is an important screen for Berkshire – it is hard to square this investment with Buffett’s historical opinions of the healthcare market,” Deutsche Bank analysts wrote in a note Friday, pointing out that Berkshire has historically invested more in providers, rather than a massive insurance operation like UnitedHealth.
Grow Therapy launched an AI companion to support patients between therapy sessions. The tool helps users journal and reflect on their emotions and offer up summaries, placing Grow among a growing number of mental health companies that are using AI as part of therapy.
New data from CMS found that 11.7 million people in the individual market didn’t file a medical claim in 2024. The conservative think tank Paragon Health Institute pointed out that is up from 3.5 million in 2021. The percentage of what Paragon calls “phantom enrollees” jumped from 19% of all enrollees in 2021 to 35% of all enrollees, which experts say may be contributing to the problems facing the ACA marketplace heading into 2026.
Oracle made its AI-enabled electronic health record available last week, after first sharing it last October.
John Carroll
Editor & Founder
Arsalan Arif
Publisher & Founder
Igor Yavych
Architect & Founder
Valentin Manov
Creative Director
Ryan McRae
Chief Revenue Officer
Amanda Florez
Chief of Staff
Drew Armstrong
Executive Editor
Liam Chua
Chief Technical Officer
Jaimy Lee
Deputy Editor
Lydia R. Pflanzer
Deputy Editor
Zachary Brennan
Senior Editor
Max Gelman
Senior Editor
Julie O'Meara
Executive Director, Brand Partnerships
Melissa Nazzaro